Invasive infections with<i>Purpureocillium lilacinum</i>: clinical characteristics and outcome of 101 cases from FungiScope® and the literature

Abstract

P. lilacinum mainly presents as soft-tissue, pulmonary or disseminated infection in immunocompromised patients. Owing to intrinsic resistance, accurate species identification and susceptibility testing are vital. Outcome is better in patients treated with triazoles compared with amphotericin B formulations.